Ibrahim Omerhodzic

Clinical Center University of Sarajevo Bosnia and Herzegovina

Dr. Ibrahim Omerhodzic, consultant neurosurgeon at University Hospital Sarajevo, is specialized in brain tumor surgery but also performs cerebrovascular and spine surgeries at daily basis. He has finished Faculty of medicine University of Sarajevo, Bosnia. As a neurosurgeon he was trained in many different countries (Germany, Sweden, Austria, USA etc.) He is also deeply focused on development of training programs in neurosurgery in Europe. He has published more than 50 articles and several book chapters and has more than 100 scientific conference presentations. Dr Omerhodzic serves as invited speaker on the most important neurosurgical meetings organized by World and continental neurosurgical societies (WFNS, EANS, AANS, ACNS). He is prominent member of Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) and active member of prestigious World Academy of Neurological Surgery (WANS).

Ibrahim Omerhodzic

1books edited

3chapters authored

Latest work with IntechOpen by Ibrahim Omerhodzic

The past three decades have been marked with huge enthusiasm from scientists and professionals in an effort to find a cure for glioma disease. Methods to confirm the kinds and grades of glioma have taken a path from classical macro- to microscopic pathohystological confirmation of tumors, through morphological-histological, molecular, and genetic diagnosis. Surgically, progress was made possible with the development and use of technological aids, for example neuronavigation, cortical mapping, electrocorticography, neuromonitoring, functional and intraoperative MRI, magnetoencephalography, etc. Great hope was placed on the extension of tumor resection and popular supratotal resection. Significant progress has been made generally in glioma treatment with the use of modern radiotherapy and new chemotherapeutics. What do we want to see for the future? By way of stem cells, a specific medicine will be produced, individualized for the particular patient, and by using a microcapsule it will be implanted into the brain zone affected by the tumor by way of robot surgery and injection needle. This is not at all an unrealistic expectation in the next decade or two.

Go to the book